Gene Expression Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Gene Expression stocks.

Gene Expression Stocks Recent News

Date Stock Title
Nov 20 A Agilent Technologies increases dividend by ~5% to $0.248
Nov 20 A Agilent Increases Cash Dividend to 24.8 Cents per Share
Nov 20 IVA Statement of total voting rights and shares forming the company’s share capital as of November 4, 2024
Nov 20 IVA Combined General Meeting of December 11, 2024 - Availability of the preparatory documents
Nov 20 SLN SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels
Nov 20 PGEN Precigen (NASDAQ:PGEN shareholders incur further losses as stock declines 13% this week, taking five-year losses to 86%
Nov 20 A Stay Ahead of the Game With Agilent (A) Q4 Earnings: Wall Street's Insights on Key Metrics
Nov 20 A Agilent 2024 Early Career Professor Award Presented to Adeyemi Adeleye
Nov 20 CSTL Castle Biosciences to Present at the Piper Sandler 36th Annual Healthcare Conference
Nov 19 A Agilent Ranks No. 11 on Fortune’s List of Best Workplaces in the World
Nov 19 SLN Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
Nov 19 CSTL CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC
Nov 19 SLN Top 3 Health Care Stocks You'll Regret Missing In Q4
Nov 19 CSTL Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fourth Consecutive Year
Nov 18 SLN Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting
Nov 18 CSTL CHMP Endorses J&J's Rybrevant-Lazcluze Combo for Use in NSCLC
Nov 18 ARWR Arrowhead Pharmaceuticals Submits New Drug Application to U.S. FDA for Plozasiran for the Treatment of Familial Chylomicronemia Syndrome
Nov 18 ARWR Arrowhead Pharmaceuticals Presents New Data at AHA24 from PALISADE Phase 3 Study and Open-Label Extension from MUIR and SHASTA-2 Studies of Plozasiran
Nov 18 IVA The first MASH drug could open the door for others — including GLP-1s
Nov 17 SLN Silence Therapeutics Third Quarter 2024 Earnings: Misses Expectations
Gene Expression

Gene expression is the process by which information from a gene is used in the synthesis of a functional gene product. These products are often proteins, but in non-protein coding genes such as transfer RNA (tRNA) or small nuclear RNA (snRNA) genes, the product is a functional RNA.
The process of gene expression is used by all known life—eukaryotes (including multicellular organisms), prokaryotes (bacteria and archaea), and utilized by viruses—to generate the macromolecular machinery for life.
Several steps in the gene expression process may be modulated, including the transcription, RNA splicing, translation, and post-translational modification of a protein. Gene regulation gives the cell control over structure and function, and is the basis for cellular differentiation, morphogenesis and the versatility and adaptability of any organism. Gene regulation may also serve as a substrate for evolutionary change, since control of the timing, location, and amount of gene expression can have a profound effect on the functions (actions) of the gene in a cell or in a multicellular organism.
In genetics, gene expression is the most fundamental level at which the genotype gives rise to the phenotype, i.e. observable trait. The genetic code stored in DNA is "interpreted" by gene expression, and the properties of the expression give rise to the organism's phenotype. Such phenotypes are often expressed by the synthesis of proteins that control the organism's shape, or that act as enzymes catalysing specific metabolic pathways characterising the organism. Regulation of gene expression is thus critical to an organism's development.

Browse All Tags